Effect of hormonal contraceptive use before HIV seroconversion on viral load setpoint among women in Rakai, Uganda

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue 2, 2011, Pages 125-130

  Polis, Chelsea B ^a   Gray, Ronald H ^a   Bwanika, J B ^a   Kigozi, Godfrey ^b   Kiwanuka, Noah ^c   Nalugoda, Fred ^b   Kagaayi, Joseph ^b   Lutalo, Tom ^b   Serwadda, David ^c   Wawer, Maria J ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^c MAKERERE UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Uganda)

Author keywords

HIV progression; hormonal contraception; Uganda; viral load setpoint

Indexed keywords

CONTRACEPTIVE AGENT; INJECTABLE CONTRACEPTIVE AGENT; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HAZARD RATIO; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROCONVERSION; SEXUALITY; SOCIAL STATUS; UGANDA; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; CONTRACEPTIVES, ORAL, HORMONAL; DRUG UTILIZATION; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MIDDLE AGED; UGANDA; VIRAL LOAD; YOUNG ADULT;

EID: 78751632675     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181fbcc11     Document Type: Article

References (27)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO), 2009 AIDS epidemic update. Geneva: UNAIDS/WHO2009.
2. Shah IH, Say L. Maternal mortality and maternity care from 1990 to 2005: uneven but important gains. Reprod Health Matters. 2007;15:17-27.
3. World Health Organization. World Health Statistics, 2010. Geneva, Switzerland: World Health Organization Press; 2010.
4. Conde-Agudelo A, Belizan JM. Maternal morbidity and mortality associated with interpregnancy interval: cross sectional study. BMJ. 2000;321:1255-1259.
5. DaVanzo J, Razzaque A, Rahman M, et al. The Effects of Birth Spacing on Infant and Child Mortality, Pregnancy Outcomes, and Maternal Mortality in Matlab Bangladesh. Working Paper 198. Santa Monica, CA: RAND Corporations Publications Department; 2004.
6. Singh S, Darroch JE, Ashford LS, et al. Adding It Up: The Costs and Benefits of Investing in Family Planning and Maternal and Newborn Health. New York, NY: Guttmacher Institute and United Nations Population Fund; 2009.
7. Sterling TR, Vlahov D, Astemborski J, et al. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Eng J Med. 2001; 344:720-725.
8. Lefrere JJ, Roudot-Thoraval F, Mariotti M, et al. The risk of disease progression is determined during the first year of human immunodeficiency virus type 1 infection. J Infect Dis. 1998;177:1541-1548.
9. Schacker TW, Hughes JP, Shea T, et al. Biological and virologic characteristics of primary HIV infection. Ann Intern Med. 1998;128: 613-620.
10. Mellors JW, Kingsley LA, Rinaldo CR, et al. Quantitation of Hiv-1 Rna in Plasma Predicts Outcome After Seroconversion. Ann Intern Med. 1995; 122:573-579.
11. Johnston MI, Fauci AS. An HIV vaccine-evolving concepts. N Eng J Med. 2007;356:2073-2081.
12. Kiwanuka N, Laeyendecker O, Robb M, et al. Effect of HIV-1 subtypes on disease progression in a cohort of incident cases infected with pure subtypes, recombinants, and multiple subtypes, Rakai, Uganda. J Infect Dis. 2008;197:707-713.
13. Lutalo T, Gray RH, Wawer M, et al. Survival of HIV-infected treatment-naive individuals with documented dates of seroconversion in Rakai, Uganda. AIDS. 2007;21(Suppl 6):S15-S19.
14. Collaborative Group on AIDS Incubation and HIV Survival. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE
15. EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet. 2000;355:1131-1137.
16. Phair J, Jacobson L, Detels R, et al. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 1992;5:490-496.
17. Sagar M, Lavreys L, Baeten JM, et al. Infection with multiple human immunodeficiency virus type 1 variants is associated with faster disease progression. J Virol. 2003;77:12921-12926.
18. Lavreys L, Baeten JM, Kreiss JK, et al. Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women. J Infect Dis. 2004;189:303-311.
19. Sagar M, Lavreys L, Baeten JM, et al. Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population. AIDS. 2004;18:615-619.
20. Kumwenda JJ, Makanani B, Taulo F, et al. Natural history and risk factors associated with early and established HIV type 1 infection among reproductive-age women in Malawi. Clin Infect Dis. 2008;46:1913-1920.
21. Morrison CS, Demers K, Kwok C, et al. Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection. AIDS. 2010;24:573-582.
22. Wawer MJ, Gray RH, Sewankambo NK, et al. A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS. 1998;12:1211-1225.
23. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet. 1999;353:525-535.
24. Polis CB, Wawer MJ, Kiwanuka N, et al. Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda. AIDS. 2010;24:1937-1944.
25. WHO. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach. Geneva, Swizerland: World Health Organization Press; 2006.
26. Wawer MJ, Serwadda D, Gray RH, et al. Trends in HIV-1 prevalence may not reflect trends in incidence in mature epidemics: data from the Rakai population-based cohort, Uganda. AIDS. 1997;11:1023-1030.
27. Sewankambo NK, Gray RH, Ahmad S, et al. Mortality associated with HIV infection in rural Rakai District, Uganda. AIDS. 2000;14:2391-2400.